Pharmaceutical Commerce - June 2019
Your serialization systems aren’t as interoperable as you might think
FDA-accepted pilot projects hope to demonstrate how industry compliance could be realized by the 2023 deadline
New science breakthroughs, and easy access to financing, propel this year’s M&A and licensing market
Will retain position until May 2020
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Why Continuous Vendor Oversight Is Key to Healthcare Data Security
2
Optimizing Your CGT Commercial Distribution Strategy: Four Priorities for a Successful Launch
3
One Connection, Endless Impact: Improving Patient Medication Access
4
Lilly Reveals Plan for New $3 Billion Manufacturing Facility in the Netherlands
5
